Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report
Abstract Neonatal hyperglycaemia is common in extremely low birth weight (ELBW,
Gespeichert in:
| Veröffentlicht in: | Neonatology 2022-03, Vol.119 (2), p.260-263 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 263 |
|---|---|
| container_issue | 2 |
| container_start_page | 260 |
| container_title | Neonatology |
| container_volume | 119 |
| creator | Desenfants, Aurelie Soleirol, Marion Salet, Randa Benito Castro, Fernando Le Guillou, Caroline Di Maio, Massimo Tran, Tu Anh |
| description | Abstract
Neonatal hyperglycaemia is common in extremely low birth weight (ELBW, |
| doi_str_mv | 10.1159/000521695 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000521695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A709902549</galeid><sourcerecordid>A709902549</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-5e588406d78158c7a2e3672a11d6fd0e17b8a924e21cc5686818eac3c9c0c6063</originalsourceid><addsrcrecordid>eNpt0c1rHCEUAHApLc1XD72XIgQCPWyiM6Pj9LYs2yawJKUfpx7EdZ5Z2xld_Cjkv6_LpEMDwcPT5-_Jw4fQW0ouKWXdFSGEVZR37AU6ppzTRSto93LeE3KETmL8VRRjvHqNjmpGa8IacYx-ro2x2oLTD9gbvPIuWZd9jvhb3uqclIPD4cbFPFhXosnReoeND_hLgFGlHADfgncqwUe8xCsVAX-FvQ_pDL0yaojw5jGeoh-f1t9X14vN3eeb1XKz0E1dpwUDJkRDeF-6ZkK3qoKat5WitOemJ0DbrVBd1UBFtWZccEEFKF3rThPNCa9P0Yfp3Z0a5D7YUYUH6ZWV18uNPORIQ9qmbrs_tNjzyd6rAaR1xqeg9GijlsuWdB2pWNMVdfmMKquH0WrvwNiSf1Jw8V_BDtSQdtEPOZW_ik_hY686-BgDmLlhSuRhmHIeZrHvJ7vP2xH6Wf6bXgHvJvBbhXsIM5jrz5-9vl3fTULue1P_Bdlmqq0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report</title><source>Karger Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Desenfants, Aurelie ; Soleirol, Marion ; Salet, Randa ; Benito Castro, Fernando ; Le Guillou, Caroline ; Di Maio, Massimo ; Tran, Tu Anh</creator><creatorcontrib>Desenfants, Aurelie ; Soleirol, Marion ; Salet, Randa ; Benito Castro, Fernando ; Le Guillou, Caroline ; Di Maio, Massimo ; Tran, Tu Anh</creatorcontrib><description>Abstract
Neonatal hyperglycaemia is common in extremely low birth weight (ELBW, <1,000 g) infants, associated with a number of adverse clinical outcomes, and usually treated with continuous intravenous insulin infusion (CIVII). We report a case of continuous subcutaneous insulin infusion (CSII) in an ELBW neonate (730 g, 25 weeks GA) requiring insulin infusion for transient idiopathic hyperglycaemia. After presenting hyperglycaemia on day 4, the patient was treated with CIVII. From day 12 to 34, CSII was used to replace central venous catheter. Insulin requirements were lower and glycaemia more stable under CSII. No side effect was noticed. CSII was also beneficial for developmental care, allowing parents to be more easily involved in their baby’s care. Thus, CSII appeared to be a safe and reliable alternative for insulin administration in ELBW infants. However, indication and management requires training of the NICU team by paediatric diabetes specialists.</description><identifier>ISSN: 1661-7800</identifier><identifier>EISSN: 1661-7819</identifier><identifier>DOI: 10.1159/000521695</identifier><identifier>PMID: 35130548</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Blood Glucose ; Care and treatment ; Child ; Diabetes Mellitus, Type 1 - drug therapy ; Humans ; Hyperglycemia ; Hyperglycemia - drug therapy ; Hypoglycemic Agents - adverse effects ; Infant ; Infant, Newborn ; Infant, Newborn, Diseases - drug therapy ; Infants (Premature) ; Injections, Subcutaneous ; Insulin ; Insulin Infusion Systems ; Life Sciences ; Novel Insights from Clinical Practice</subject><ispartof>Neonatology, 2022-03, Vol.119 (2), p.260-263</ispartof><rights>2022 S. Karger AG, Basel</rights><rights>2022 S. Karger AG, Basel.</rights><rights>COPYRIGHT 2022 S. Karger AG</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-5e588406d78158c7a2e3672a11d6fd0e17b8a924e21cc5686818eac3c9c0c6063</citedby><cites>FETCH-LOGICAL-c433t-5e588406d78158c7a2e3672a11d6fd0e17b8a924e21cc5686818eac3c9c0c6063</cites><orcidid>0000-0002-5503-6612</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35130548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04074379$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Desenfants, Aurelie</creatorcontrib><creatorcontrib>Soleirol, Marion</creatorcontrib><creatorcontrib>Salet, Randa</creatorcontrib><creatorcontrib>Benito Castro, Fernando</creatorcontrib><creatorcontrib>Le Guillou, Caroline</creatorcontrib><creatorcontrib>Di Maio, Massimo</creatorcontrib><creatorcontrib>Tran, Tu Anh</creatorcontrib><title>Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report</title><title>Neonatology</title><addtitle>Neonatology</addtitle><description>Abstract
Neonatal hyperglycaemia is common in extremely low birth weight (ELBW, <1,000 g) infants, associated with a number of adverse clinical outcomes, and usually treated with continuous intravenous insulin infusion (CIVII). We report a case of continuous subcutaneous insulin infusion (CSII) in an ELBW neonate (730 g, 25 weeks GA) requiring insulin infusion for transient idiopathic hyperglycaemia. After presenting hyperglycaemia on day 4, the patient was treated with CIVII. From day 12 to 34, CSII was used to replace central venous catheter. Insulin requirements were lower and glycaemia more stable under CSII. No side effect was noticed. CSII was also beneficial for developmental care, allowing parents to be more easily involved in their baby’s care. Thus, CSII appeared to be a safe and reliable alternative for insulin administration in ELBW infants. However, indication and management requires training of the NICU team by paediatric diabetes specialists.</description><subject>Blood Glucose</subject><subject>Care and treatment</subject><subject>Child</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Hyperglycemia - drug therapy</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Newborn, Diseases - drug therapy</subject><subject>Infants (Premature)</subject><subject>Injections, Subcutaneous</subject><subject>Insulin</subject><subject>Insulin Infusion Systems</subject><subject>Life Sciences</subject><subject>Novel Insights from Clinical Practice</subject><issn>1661-7800</issn><issn>1661-7819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0c1rHCEUAHApLc1XD72XIgQCPWyiM6Pj9LYs2yawJKUfpx7EdZ5Z2xld_Cjkv6_LpEMDwcPT5-_Jw4fQW0ouKWXdFSGEVZR37AU6ppzTRSto93LeE3KETmL8VRRjvHqNjmpGa8IacYx-ro2x2oLTD9gbvPIuWZd9jvhb3uqclIPD4cbFPFhXosnReoeND_hLgFGlHADfgncqwUe8xCsVAX-FvQ_pDL0yaojw5jGeoh-f1t9X14vN3eeb1XKz0E1dpwUDJkRDeF-6ZkK3qoKat5WitOemJ0DbrVBd1UBFtWZccEEFKF3rThPNCa9P0Yfp3Z0a5D7YUYUH6ZWV18uNPORIQ9qmbrs_tNjzyd6rAaR1xqeg9GijlsuWdB2pWNMVdfmMKquH0WrvwNiSf1Jw8V_BDtSQdtEPOZW_ik_hY686-BgDmLlhSuRhmHIeZrHvJ7vP2xH6Wf6bXgHvJvBbhXsIM5jrz5-9vl3fTULue1P_Bdlmqq0</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Desenfants, Aurelie</creator><creator>Soleirol, Marion</creator><creator>Salet, Randa</creator><creator>Benito Castro, Fernando</creator><creator>Le Guillou, Caroline</creator><creator>Di Maio, Massimo</creator><creator>Tran, Tu Anh</creator><general>S. Karger AG</general><general>Karger</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-5503-6612</orcidid></search><sort><creationdate>20220301</creationdate><title>Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report</title><author>Desenfants, Aurelie ; Soleirol, Marion ; Salet, Randa ; Benito Castro, Fernando ; Le Guillou, Caroline ; Di Maio, Massimo ; Tran, Tu Anh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-5e588406d78158c7a2e3672a11d6fd0e17b8a924e21cc5686818eac3c9c0c6063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood Glucose</topic><topic>Care and treatment</topic><topic>Child</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Hyperglycemia - drug therapy</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Newborn, Diseases - drug therapy</topic><topic>Infants (Premature)</topic><topic>Injections, Subcutaneous</topic><topic>Insulin</topic><topic>Insulin Infusion Systems</topic><topic>Life Sciences</topic><topic>Novel Insights from Clinical Practice</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desenfants, Aurelie</creatorcontrib><creatorcontrib>Soleirol, Marion</creatorcontrib><creatorcontrib>Salet, Randa</creatorcontrib><creatorcontrib>Benito Castro, Fernando</creatorcontrib><creatorcontrib>Le Guillou, Caroline</creatorcontrib><creatorcontrib>Di Maio, Massimo</creatorcontrib><creatorcontrib>Tran, Tu Anh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Neonatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desenfants, Aurelie</au><au>Soleirol, Marion</au><au>Salet, Randa</au><au>Benito Castro, Fernando</au><au>Le Guillou, Caroline</au><au>Di Maio, Massimo</au><au>Tran, Tu Anh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report</atitle><jtitle>Neonatology</jtitle><addtitle>Neonatology</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>119</volume><issue>2</issue><spage>260</spage><epage>263</epage><pages>260-263</pages><issn>1661-7800</issn><eissn>1661-7819</eissn><abstract>Abstract
Neonatal hyperglycaemia is common in extremely low birth weight (ELBW, <1,000 g) infants, associated with a number of adverse clinical outcomes, and usually treated with continuous intravenous insulin infusion (CIVII). We report a case of continuous subcutaneous insulin infusion (CSII) in an ELBW neonate (730 g, 25 weeks GA) requiring insulin infusion for transient idiopathic hyperglycaemia. After presenting hyperglycaemia on day 4, the patient was treated with CIVII. From day 12 to 34, CSII was used to replace central venous catheter. Insulin requirements were lower and glycaemia more stable under CSII. No side effect was noticed. CSII was also beneficial for developmental care, allowing parents to be more easily involved in their baby’s care. Thus, CSII appeared to be a safe and reliable alternative for insulin administration in ELBW infants. However, indication and management requires training of the NICU team by paediatric diabetes specialists.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>35130548</pmid><doi>10.1159/000521695</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-5503-6612</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1661-7800 |
| ispartof | Neonatology, 2022-03, Vol.119 (2), p.260-263 |
| issn | 1661-7800 1661-7819 |
| language | eng |
| recordid | cdi_crossref_primary_10_1159_000521695 |
| source | Karger Journals; MEDLINE; Alma/SFX Local Collection |
| subjects | Blood Glucose Care and treatment Child Diabetes Mellitus, Type 1 - drug therapy Humans Hyperglycemia Hyperglycemia - drug therapy Hypoglycemic Agents - adverse effects Infant Infant, Newborn Infant, Newborn, Diseases - drug therapy Infants (Premature) Injections, Subcutaneous Insulin Insulin Infusion Systems Life Sciences Novel Insights from Clinical Practice |
| title | Efficiency of Continuous Subcutaneous Insulin Infusion for Premature Neonate: A Case Report |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A42%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficiency%20of%20Continuous%20Subcutaneous%20Insulin%20Infusion%20for%20Premature%20Neonate:%20A%20Case%20Report&rft.jtitle=Neonatology&rft.au=Desenfants,%20Aurelie&rft.date=2022-03-01&rft.volume=119&rft.issue=2&rft.spage=260&rft.epage=263&rft.pages=260-263&rft.issn=1661-7800&rft.eissn=1661-7819&rft_id=info:doi/10.1159/000521695&rft_dat=%3Cgale_cross%3EA709902549%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35130548&rft_galeid=A709902549&rfr_iscdi=true |